What Is Autoimmune Hepatitis? PDF Print E-mail
Friday, 09 October 2009 10:16
Autoimmune hepatitis is an inflammation of the liver caused by an autoimmune disorder. An autoimmune disorder is one in which a person's immune system attacks his or her own body for unknown reasons. The degree of liver inflammation can range from mild to deadly.

The cause of autoimmune hepatitis is unknown. It may be an isolated condition or may occur as part of another autoimmune disorder, such as systemic lupus erythematosus. Autoimmune hepatitis most often occurs in women between the ages of 15 and 40. While the condition is seen in men, it is eight times more common in women.

New research findings suggest that autoimmune disorders may be triggered by a transfer of cells between the fetus and the mother during pregnancy. The study involved women with Scleroderma, an autoimmune disorder involving the skin. These women have more fetal cells in their blood decades after a pregnancy than women who don't have Scleroderma. While further research is needed to substantiate these findings, the study does offer an explanation for the much higher incidence of autoimmune disorders in women than in men.

The outcome for autoimmune hepatitis is often unpredictable. A person may require lifelong therapy or the condition may go away on its own for long stretches of time. Autoimmune hepatitis can be treated with medications that stop the immune system from attacking the liver, including steroids, such as prednisone, and azathioprine. A liver transplant may be needed if medications don't work or the liver becomes very damaged.

Fatigue is probably the most common symptom of autoimmune hepatitis. Other symptoms include
  • an enlarged liver
  • jaundice
  • itching
  • skin rashes
  • joint pain
  • abdominal discomfort
  • spider angiomas, or abnormal blood vessels, on the skin
  • nausea
  • vomiting
  • loss of appetite
  • dark urine
  • pale or gray-colored stools

Regular physical examinations or liver biopsies and liver function blood tests are commonly used to monitor autoimmune hepatitis. Any new or worsening symptoms should be reported to your doctor. For more detailed reading on Autoimmune Hepatitis, visit The National Digestive Diseases Information Clearinghouse (NDDIC) here, or at the MayoClinic.com, here. For a link back to the full article by Glenn Rosenberg, click here.
 
More articles :

» Moves Toward Personalized Medicine for Scleroderma

researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study , an autoimmune disease for which there currently is no...

» Lupus, A Widespread and Chronic Autoimmune Disease

Lupus is a widespread and chronic disease that, for unknown reasons, causes the immune system to attack the body’s own tissues and organs, including the joints, kidneys, heart, lungs, brain and skin. Lupus, an important disease for...

» Scleroderma May Be Initated By Cancer

has reported that researchers at have discovered that some cases of are likely to have been initiated by Cancer.  In a landmark paper published in Science, researchers focusing on a select group of patients with both Scleroderma and Cancer,...

» Optical Coherence Tomography: The first Quantitative Imaging Biomarker for Scleroderma

Using the , manufactured in the UK by Michelson Diagnostics Ltd, scientists at the Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds have developed the first quantitative imaging biomarker for skin involvement in . Scleroderma...

» Patients With Scleroderma May Not Exhibit Increased Corneal Thickness

in patients with systemic sclerosis may not differ significantly from those of healthy patients, contrary to prior hypothesis, a study found."Because [] is characterized by increased deposition of and other connective tissue components in the skin...

» B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

Dimitrios Daoussis, Stamatis-Nick C. Liossis, Georgios Yiannopoulos, and Andrew P. AndonopoulosDivision of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504 Patras,...